Browse by specialty
Adult Reconstructive Orthopaedic Surgery
In 2025, 1,076 Adult Reconstructive Orthopaedic Surgery providers had general (non-research) payments reported to CMS. Half received less than $1,425 for the year, and nine in ten received less than $73K.
1,076providers with payments in 2025
$1,425median total for the year
$73Knine in ten received less than
$78Kaverage total for the year
Providers with the largest 2025 totals
Ordered by 2025 general-payment totals as reported to CMS. A large total is not evidence of wrongdoing; context is below the table.
| Provider | Location | 2025 general | All payments 2019-2025 including research |
|---|---|---|---|
| Nitin Goyal | Arlington, VA | $30,000,067.88 | $81,510,979.47 |
| Robert M Meneghini | Indianapolis, IN | $2,038,402.03 | $10,136,191.50 |
| Adolph V Lombardi | New Albany, OH | $2,010,951.63 | $14,729,786.86 |
| Robert L Barrack | Saint Louis, MO | $1,867,655.75 | $11,314,958.19 |
| Michael A Mont | Baltimore, MD | $1,762,551.28 | $10,963,803.58 |
| William Joseph Maloney | Stanford, CA | $1,622,216.66 | $11,140,279.91 |
| Viktor E Krebs | Cleveland, OH | $1,520,532.37 | $7,533,936.18 |
| Seth A Jerabek | New York, NY | $1,432,165.38 | $7,090,964.65 |
| William G Hamilton | Alexandria, VA | $1,418,584.42 | $9,253,889.75 |
| Christopher L Peters | Salt Lake City, UT | $1,397,005.41 | $7,608,388.24 |
| Atul F Kamath | Manasquan, NJ | $1,311,389.22 | $4,047,516.70 |
| Antonia Chen | Dallas, TX | $1,127,899.40 | $3,805,142.24 |
| Jose A Rodriguez | New York, NY | $1,125,905.65 | $3,371,274.50 |
| James V Bono | Boston, MA | $1,122,653.49 | $6,262,778.81 |
| Michael A Masini | Ypsilanti, MI | $1,117,163.78 | $6,287,544.89 |
| Scott Sporer | Winfield, IL | $1,038,238.09 | $5,335,606.85 |
| James O Browne | Charlottesville, VA | $1,025,793.69 | $4,761,143.50 |
| Anthony S Unger | Washington, DC | $969,319.28 | $1,587,675.51 |
| Javad Parvizi | Philadelphia, PA | $910,969.35 | $2,826,599.57 |
| Denis Nam | Chicago, IL | $887,844.86 | $3,206,168.85 |
| Carlos J Lavernia | Miami, FL | $886,507.42 | $5,446,310.91 |
| Jeffrey Hilliard Declaire | Rochester, MI | $869,244.66 | $5,469,016.81 |
| Roshan P Shah | New York, NY | $866,425.12 | $1,316,323.68 |
| William J Long | New York, NY | $853,628.48 | $1,545,589.47 |
| Cory L Calendine | Franklin, TN | $783,966.74 | $2,518,923.37 |
| Nicolas Santiago Piuzzi | Cleveland, OH | $749,838.75 | $1,415,727.13 |
| Ryan M Nunley | Saint Louis, MO | $725,789.43 | $3,944,573.62 |
| David Carl Pollock | Bermuda Run, NC | $671,592.98 | $4,841,313.40 |
| James T Caillouette | Newport Beach, CA | $671,431.25 | $4,806,271.63 |
| Linda I Suleiman | Chicago, IL | $657,046.35 | $897,883.87 |
| James Huddleston | Stanford, CA | $622,838.08 | $1,520,882.83 |
| Peter Keyes Sculco | New York, NY | $595,048.68 | $1,462,870.53 |
| Craig J Della Valle | Chicago, IL | $581,619.13 | $2,351,668.93 |
| Nathan G Momberger | Murray, UT | $568,150.18 | $3,018,290.97 |
| Thomas L Bradbury | Atlanta, GA | $565,566.83 | $1,921,672.92 |
| Nathanael David Heckmann | Los Angeles, CA | $536,848.57 | $722,419.48 |
| Friedrich Boettner | New York, NY | $489,531.37 | $2,870,963.88 |
| Thorsten M Seyler | Durham, NC | $436,814.01 | $2,302,348.53 |
| Jonathan Matthew Vigdorchik | New York, NY | $428,733.93 | $2,506,811.15 |
| Hany Salah Bedair | Chicago, IL | $406,160.95 | $1,073,132.50 |
| William D Bugbee | La Jolla, CA | $371,195.78 | $2,065,419.47 |
| Armodios Miltiadis Hatzidakis | Denver, CO | $362,455.08 | $1,427,735.52 |
| Michael D Ries | Reno, NV | $347,069.06 | $7,650,885.58 |
| Kirk Kindsfater | Fort Collins, CO | $337,567.51 | $578,122.91 |
| David N Collins | Little Rock, AR | $322,601.47 | $2,368,005.96 |
| Matthew S Austin | New York, NY | $312,550.01 | $986,212.78 |
| John W Barrington | Plano, TX | $312,540.42 | $2,195,432.84 |
| Vivek M Shah | Boston, MA | $261,778.02 | $1,449,215.84 |
| Stephen T Duncan | Lexington, KY | $241,403.38 | $789,333.75 |
| Steven Keita Nishiyama | Las Vegas, NV | $237,328.01 | $835,523.93 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026).